Clinical Trial Update: T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating infusion of regulatory T cells after umbilical cord blood transplant in patients with advanced hematologic cancers; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Plasma Cell Neoplasm

Drugs mentioned

• T-regulatory cell infusion (Regulatory T-cell infusion)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Leukemia, Lymphoma | Phase 1 | Status: COMPLETED